{
    "id": 22458,
    "fullName": "CHKA over exp",
    "impact": "none",
    "proteinEffect": "no effect",
    "geneVariantDescriptions": [
        {
            "description": "CHKA over exp indicates an over expression of the ChkA protein. However, the mechanism causing the over expression is unspecified.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 1119,
        "geneSymbol": "CHKA",
        "terms": [
            "CHKA",
            "CHK",
            "CK",
            "CKI",
            "EK"
        ]
    },
    "variant": "over exp",
    "createDate": "05/11/2016",
    "updateDate": "10/24/2018",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 6237,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, MN58b induced apoptosis and decreased growth of pancreatic ductal adenocarcinoma cell lines with high levels of CHKA expression in culture (PMID: 26769123).",
            "molecularProfile": {
                "id": 23039,
                "profileName": "CHKA over exp"
            },
            "therapy": {
                "id": 4102,
                "therapyName": "MN58b",
                "synonyms": null
            },
            "indication": {
                "id": 3498,
                "name": "pancreatic ductal adenocarcinoma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 5504,
                    "pubMedId": 26769123,
                    "title": "Choline Kinase Alpha (CHK\u03b1) as a Therapeutic Target in Pancreatic Ductal Adenocarcinoma: Expression, Predictive Value, and Sensitivity to Inhibitors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26769123"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 15113,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, TCD-717 treatment of colorectal cancer cells with elevated expression of Chka demonstrated decreased cell viability upon treatment (PMID: 23762272).",
            "molecularProfile": {
                "id": 23039,
                "profileName": "CHKA over exp"
            },
            "therapy": {
                "id": 7416,
                "therapyName": "TCD-717",
                "synonyms": null
            },
            "indication": {
                "id": 9256,
                "name": "colorectal cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 12651,
                    "pubMedId": 23762272,
                    "title": "Combined 5-FU and ChoK\u03b1 inhibitors as a new alternative therapy of colorectal cancer: evidence in human tumor-derived cell lines and mouse xenografts.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/23762272"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 23039,
            "profileName": "CHKA over exp",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}